Polystyrene microplastic-induced pathophysiology is driven by disruption of efferocytosis

Ana C Codo1, Jesus E Romero-Pichardo2, Zhaoquan Wang1

  • 1Immunology & Microbial Pathogenesis Graduate Program, Weill Cornell Graduate School of Medical Sciences, New York, NY, USA; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Immunity
|February 26, 2026
PubMed

Insights

Microplastics (MPs) impair the immune system's ability to clear dead cells, a process called efferocytosis. This disruption leads to organ damage and impaired cellular functions due to metabolic changes.

Area of Science:

  • Environmental Health
  • Immunology
  • Toxicology

Background:

  • Microplastics (MPs) are pervasive pollutants with potential human health risks.
  • Macrophages are crucial immune cells for clearing cellular debris, a process known as efferocytosis.
  • MP accumulation may compromise efferocytosis, leading to impaired immune function and organ damage.

Purpose of the Study:

  • To investigate the impact of polystyrene microplastics (PS-MPs) on efferocytosis.
  • To elucidate the mechanisms by which PS-MPs disrupt efferocytosis.
  • To assess the in vivo effects of PS-MPs on organ health and efferocytosis.

Main Methods:

  • In vitro studies using macrophages and Sertoli cells exposed to PS-MPs.
  • In vivo studies assessing PS-MP effects on lungs, liver, and testes.
  • Analysis of metabolic and phagolysosome processes in MP-exposed cells.
  • Investigating the role of methylglyoxal (MGO) and glyoxalase-1.

Main Results:

  • PS-MP accumulation disrupted efferocytosis by impairing apoptotic cell digestion in macrophages and Sertoli cells.
  • In vivo, PS-MP exposure suppressed efferocytosis and caused organ damage in lungs, liver, and testes.
  • Mechanistically, PS-MPs led to methylglyoxal accumulation and impaired glucose-6-phosphate dehydrogenase, hindering efferocytosis.

Conclusions:

  • PS-MPs directly disrupt efferocytosis, impacting cellular functions and organ health.
  • Methylglyoxal accumulation is a key mechanism in PS-MP-induced efferocytosis defects.
  • Overexpression of glyoxalase-1 can mitigate PS-MP-induced efferocytosis impairment.